Area of research
Oncology · Physiology
Research interest
Research interests include Nutrition and Health in Aging, Cancer Immunotherapy and Biomarkers, Chronic Kidney Disease and Diabetes, and GDF15 and Related Biomarkers.
Hepatic gluconeogenesis and PDK3 upregulation drive cancer cachexia in flies and mice
Cancer-Associated Cachexia: Bridging Clinical Findings with Mechanistic Insights in Human Studies
A guideline on the molecular ecosystem regulating ferroptosis
Why do patients with cancer die?
Dietary pro-oxidant therapy by a vitamin K precursor targets PI 3-kinase VPS34 function
Analysis and Optimization of Equitable US Cancer Clinical Trial Center Access by Travel Time
Cachexia: A systemic consequence of progressive, unresolved disease
Ketogenic diet promotes tumor ferroptosis but induces relative corticosterone deficiency that accelerates cachexia
Data from CamGFR v2: A New Model for Estimating the Glomerular Filtration Rate from Standardized or Non-standardized Creatinine in Patients with Cancer
Abstract 1162: Ketogenic diet promotes tumor ferroptosis but induces relative corticosterone deficiency that accelerates cachexia
Carcinomas assemble a filamentous CXCL12-keratin-19 coating that suppresses T cell-mediated immune attack.
Neurotensin neurons in the extended amygdala control dietary choice and energy homeostasis
A framework for advancing our understanding of cancer-associated fibroblasts
CXCR4 inhibition in human pancreatic and colorectal cancers induces an integrated immune response
CXCR4 inhibition in human pancreatic and colorectal cancers induces an integrated immune response
CamGFR v2: A New Model for Estimating the Glomerular Filtration Rate from Standardized or Non-standardized Creatinine in Patients with Cancer
Oncogenic KRAS Reduces Expression of FGF21 in Acinar Cells to Promote Pancreatic Tumorigenesis in Mice on a High-Fat Diet
Multicenter Validation of the CamGFR Model for Estimated Glomerular Filtration Rate
A comparative analysis of immune privilege in pregnancy and cancer in the context of checkpoint blockade immunotherapy
A type III complement factor D deficiency: Structural insights for inhibition of the alternative pathway
Cancer: The Tumor-Driven Disease of the Host
Validation of a new model for estimating glomerular filtration rate in patients with cancer.
A molecular and preclinical comparison of the PD-1–targeted T-cell checkpoint inhibitors nivolumab and pembrolizumab
Connecting the Metabolic and Immune Responses to Cancer
Cancer immunotherapy trial registrations increase exponentially but chronic immunosuppressive glucocorticoid therapy may compromise outcomes
Cancer Immunotherapy Trials Underutilize Immune Response Monitoring
A new model for estimating glomerular filtration rate in patients with cancer.
Tumor-Induced IL-6 Reprograms Host Metabolism to Suppress Anti-tumor Immunity
The use of error-category mapping in pharmacokinetic model analysis of dynamic contrast-enhanced MRI data
Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti–PD-L1 immunotherapy in pancreatic cancer